FDA Approves Moderna's mRNA Flu Vaccine. StringersHub Aug 6, 2026 Aug 6, 2026 Updated 3 hrs ago 0 Hidden Walkable Cities You Need to Visit in 2026 US tariffs: New duties aimed at over 80 countries Is Winning a Football National Championship Tougher Today? RAW: OPEC TO INCREASE SEPTEMBER PRODUCTION Council member Doug Lanfear discusses the issues Ceuta enclave "almost" back to normal after migrant influx Cheba Hut opens Lincoln location in the Telegraph District Fair contests culminate with Beef Showmanship Funeral Procession for Crete Police Chief Gary Young Masters Of The Game: The Winningest Head Coaches In WNBA History Sam McKewon recaps Wednesday at Big Ten Media Days Ames Avenue Safe Mobility Recovery Plan John Harbaugh address the team before 2026 training camp City of Omaha addresses intersection the week after a fatal crash Creativity on display Livestock Costume Contest Showing market beef at the Scotts Bluff County Fair Iran threatens wider attacks as war expands; Trump set for prime-time address Prefer us on Google Learn More The U.S. Food and Drug Administration (FDA) has approved Moderna's mRNA seasonal flu vaccine, mFLUSIVA. As featured on US FDA approves first mRNA flu shot from Moderna The FDA has approved Moderna's flu vaccine for people aged 50 and older, marking the first approval of a messenger RNA-based vaccine for seasonal flu. Latest video RAW: DC: FAUCI CONTEMPT VOTE/PAUL: REASON FOR VOTE FDA Approves Moderna's mRNA Flu Vaccine. Trump: Deal to open Strait of Hormuz could happen any moment Hidden in Plain Sight: Trailer spotlights concerns Nebraska volleyball's championship mindset | Pick Six Podcast Axtell veterans memorial What Actually Happens When You Stop GLP-1 Weight Loss Drugs Who is Abdul El-Sayed, Michigan Democrats' best hope at taking back the Senate? Facebook Twitter Bluesky WhatsApp SMS Email Print Copy article link Save 0 Comments
US FDA approves first mRNA flu shot from Moderna The FDA has approved Moderna's flu vaccine for people aged 50 and older, marking the first approval of a messenger RNA-based vaccine for seasonal flu.
